Navigation Links
Meredith Martin Addy Named Chair of AIPLA's Amicus Committee
Date:11/2/2007

CHICAGO, Nov. 2 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the United States, is pleased to announce that Meredith Martin Addy, a shareholder and chair of the firm's Appellate Group, has been appointed chair of the Amicus Committee of the American Intellectual Property Law Association (AIPLA).

AIPLA is a national bar association with more than 16,000 members, primarily lawyers, involved in the practice of patent, trademark, copyright and unfair competition law. AIPLA is actively involved in shaping U.S. intellectual property policy through its work on legislation, federal regulations and intellectual property cases in the U.S. courts. The AIPLA Amicus Committee considers requests to review cases for possible AIPLA amicus participation and provides a strong collective voice in the Courts, in Congress, with the U.S. Patent and Trademark Office and international organizations. The Amicus Committee has filed amici briefs in many of today's front-page, high-stakes cases.

Ms. Addy focuses her practice on intellectual property litigation, including appeals before the U.S. Court of Appeals for the Federal Circuit. She has litigated patents in the biotech, pharmaceutical, chemical and electrical arts before courts at all stages, including the U.S. Supreme Court. She has testified on the state of the Federal Circuit and patent appeals before the United States House of Representatives, Committee on the Judiciary, Subcommittee on Courts, the Internet and Intellectual Property. She is also an experienced Court Appointed Assistant and Special Master. Ms. Addy is a member of the Federal Circuit Advisory Council and serves as founding president of the Richard Linn American Inn of Court.

Founded in 1917, Brinks Hofer Gilson & Lione is based in Chicago with four additional offices across the country serving the intellectual property needs of clients from around the world. The firm is one of the largest IP law firms in the country, with more than 160 attorneys, scientific advisors and patent agents specializing in intellectual property litigation and all aspects of patent, trademark, copyright, trade secret, unfair competition, intellectual asset management, and technology and licensing agreements. Brinks routinely handles assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology, Internet and computer technology, as well as in trademarks and brand names for a wide variety of products and services. For more information, visit http://www.usebrinks.com.

CONTACT:

Sydney Iglitzen

(312) 840-3163

siglitzen@usebrinks.com


'/>"/>
SOURCE Brinks Hofer Gilson & Lione
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Bruce Maas named CIO at UW-Milwaukee
2. Three finalists named for UW-Madison CIO
3. Eight lawmakers named to Speakers IT task force
4. Hospital named for Madame Curie installs TomoTherapy system
5. Two UW-Madison professors named to National LambdaRail Networking Research Council
6. UW researcher named top innovator
7. Alzheimers drug firm and more winners named in Wisconsin business-plan contest
8. Inacom named Microsofts favorite learning solutions partner of the year
9. Five Wisconsin CIOs named top in nation
10. Deltanoid named to top-15 list of biotech companies
11. Kyron appoints former AMA chairman to board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... -- Summary This report provides all the ... partnering interests and activities since 2010. Description The Partnering ... into the partnering activity of one of the world,s leading ... prepared upon purchase to ensure inclusion of the most up ... will be delivered in PDF format within 1 working day ...
(Date:3/28/2017)... March 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... of novel therapies for metabolic and endocrine disorders, today ... , Ph.D., will deliver a corporate presentation at H.C. ... Conference, being held April 3, 2017 at the St. ... for this presentation are as follows: ...
(Date:3/28/2017)... ... March 28, 2017 , ... Currently symptomatic therapies for ... recent study published in STEM CELLS suggests that human neural stem cell (hNSC) ... to produce more neural cells. , Strategies involving transplantation of these cells ...
(Date:3/28/2017)... Triangle Park, NC (PRWEB) , ... March 28, ... ... development company engaged in the development of a new orally administered treatment for ... Advisory Board. , CEO John Didsbury states, “As we seek to uniquely treat ...
Breaking Biology Technology:
(Date:2/16/2017)... 2017  Genos, a community for personal genetic ... received Laboratory Accreditation from the College of American ... laboratories that meet stringent requirements around quality, accuracy ... "Genos is committed to maintaining the ... honored to be receiving CAP accreditation," said ...
(Date:2/13/2017)... SAN FRANCISCO , Feb. 13, 2017 /PRNewswire/ ... a centralized platform that is designed to enhance ... the latest release in the RSA Fraud & ... to enable organizations to leverage additional insights from ... anti-fraud tools to better protect their customers from ...
(Date:2/10/2017)... Research and Markets has announced the addition of ... Commercial Aspects" to their offering. ... Biomarkers play an important ... selection of treatment as well for monitoring the results. There ... modern medicine. Biochip/microarray technologies and next generation sequencing are also ...
Breaking Biology News(10 mins):